AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


American Journal of Public Health, Vol. 73, Issue 10 1186-1189, Copyright © 1983 by American Public Health Association

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huether, C A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huether, C A
Projection of Down's syndrome births in the United States 1979-2000, and the potential effects of prenatal diagnosis.

C A Huether

This study projects the annual number of Down's syndrome (DS) births during 1979-2000 by maternal age categories, and estimates the effects of prenatal chromosomal diagnosis utilization on reducing these baseline projections. Assuming no reduction in DS births through prenatal diagnosis, projected DS births increase from about 4,300 in 1979 to 5,300 in 1990, where the level would remain approximately stable throughout the 1990s. Applying Ohio's 1980-1981 prenatal chromosomal diagnosis utilization ratio of 17 per cent to women greater than or equal to 35 results in a maximum of 6 per cent reduction in the annual baseline projections of DS births over the next two decades. However, if amniocentesis utilization by women age 30-34 increases to 37.5 per cent and to 75 per cent by women greater than or equal to 35, a one-fourth to one-third annual reduction is achieved throughout the period studied. A substantial increase in prenatal diagnosis appears necessary to offset the projected increase in DS births resulting from a larger number of births to women greater than or equal to 35.




This article has been cited by other articles:


Home page
Obstet GynecolHome page
J. F. X. EGAN, P. BENN, A. F. BORGIDA, J. F. RODIS, W. A. CAMPBELL, and A. M. VINTZILEOS
Efficacy of Screening for Fetal Down Syndrome in the United States From 1974 to 1997
Obstet. Gynecol., December 1, 2000; 96(6): 979 - 985.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by the American Public Health Association